What Is Heterogeneous Plaque and Is It Dangerous?

Heterogeneous plaque is an atherosclerotic deposit in an artery wall that contains a mix of tissue types, including soft fatty material, fibrous tissue, calcium deposits, and sometimes hemorrhage. It is considered more dangerous than a uniform, homogeneous plaque because its mixed composition signals biological instability, and that instability raises the risk of stroke, heart attack, and other cardiovascular events. The term shows up most often in carotid ultrasound reports, but the concept applies to plaques throughout the arterial system, and the evidence linking heterogeneous plaque to worse outcomes is more dramatic than many patients realize.

What “Heterogeneous” Actually Means on an Imaging Report

When a doctor describes a plaque as heterogeneous, they are describing its internal texture as seen on imaging, usually ultrasound. A homogeneous plaque looks roughly the same throughout, returning a uniform signal on the screen. A heterogeneous plaque, by contrast, is a patchwork. On ultrasound, it appears as a mix of bright areas (dense calcium), medium-gray zones (fibrous tissue), and dark regions (soft, lipid-rich material or hemorrhage). Formally, researchers define it as a lesion containing a mix of hyperechoic, isoechoic, and hypoechoic areas.1PubMed Central. Heterogeneous Carotid Plaque Predicts Cardiovascular Events after Percutaneous Coronary Intervention

Histological studies confirm that these imaging differences reflect real structural variation. Heterogeneous plaques tend to contain more calcification than homogeneous ones, though the amount of soft tissue inside them does not necessarily differ.2European Journal of Vascular and Endovascular Surgery. Carotid Artery Plaque Composition—Relationship to Clinical Presentation and Ultrasound B-mode Imaging What makes them worrisome is not any single component but the combination. A plaque that has soft lipid sitting next to hard calcium and fibrous tissue experiences uneven mechanical stresses. And when the soft, fatty core is large enough to push against a thin fibrous cap, the plaque becomes prone to rupture.

Why Mixed Composition Equals Instability

The danger of heterogeneous plaque comes down to what is happening inside it at a microscopic level. Plaques do not just sit passively on the artery wall. They are living tissue, infiltrated by immune cells and fed by tiny blood vessels called vasa vasorum. These microvessels grow into the plaque from the outer wall of the artery, and they are often immature and leaky. When they rupture internally, red blood cells flood the plaque interior, a process called intraplaque hemorrhage.3PubMed Central. Vasa vasorum in atherosclerosis and clinical significance

That hemorrhage dumps a load of cholesterol from red blood cell membranes into the plaque’s fatty core, expanding it rapidly. Macrophages flood in trying to clean up the debris, fueling inflammation. The result is an abrupt shift in the plaque’s internal makeup: the lipid core swells, the fibrous cap thins under the pressure, and the whole structure becomes more likely to crack open.4PubMed. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage When the cap does rupture, the fatty core is exposed to flowing blood, triggering a clot that can block the artery or break loose and travel to the brain or heart.5JVS-Vascular Science. Review of imaging biomarkers for the vulnerable carotid plaque

This is the mechanism that makes heterogeneous plaque more than just a cosmetic label on an ultrasound. The mixed appearance is a visible marker of the biological chaos happening underneath, and it often means the plaque is actively remodeling and moving toward a more dangerous state.

The Stroke Risk Numbers Are Striking

One of the most cited studies on this question compared the rate of neurological symptoms in patients with heterogeneous versus homogeneous carotid plaques at various levels of artery narrowing. The results were stark. Even in people with less than 50% narrowing of the carotid artery, those with heterogeneous plaque had symptoms about 68% of the time, compared with just 16% for homogeneous plaque. At the most severe narrowing (70–99%), the gap widened to 86% versus 31%. The odds ratios climbed as narrowing increased, reaching nearly 14 at the highest grades, but the researchers found that heterogeneity itself was more strongly correlated with symptoms than the degree of stenosis alone.6PubMed. Carotid plaque ultrasonic heterogeneity and severity of stenosis

That finding is worth pausing on, because clinical guidelines have traditionally focused heavily on how narrow the artery is when deciding whether to intervene. The evidence suggests that what the plaque looks like inside matters at least as much. Multiple published reports reinforce this, showing that when heterogeneous plaques are present, the incidence of neurological symptoms and stroke on follow-up goes up relative to patients whose plaques are uniform in texture.7Seminars in Ultrasound, CT and MRI. Evaluation and characterization of carotid plaque

A prospective natural-history study of patients with moderate (60–69%) asymptomatic carotid stenosis reinforced this pattern. Patients whose plaques were heterogeneous had a higher rate of late stroke, transient ischemic attacks, and progression to more severe stenosis than those with homogeneous plaques. The authors concluded that preventive surgery for moderate asymptomatic narrowing could be justified when the plaque is heterogeneous.8PubMed. Prospective controlled study of the natural history of asymptomatic 60% to 69% carotid stenosis according to ultrasonic plaque morphology

Risk in the Heart’s Own Arteries

The concept of a dangerous, mixed-composition plaque applies in the coronary arteries too, though cardiologists tend to describe it using slightly different vocabulary. Instead of “heterogeneous,” coronary CT angiography reports may flag features like low-attenuation areas (dark spots indicating a large fatty core), spotty calcification, positive remodeling (outward bulging of the vessel wall), and the “napkin-ring sign,” where a dark central core is surrounded by a brighter rim. These features collectively describe a coronary plaque that is structurally mixed and, in many cases, vulnerable.9US Cardiology Review. Vulnerable Plaque in Patients with Acute Coronary Syndrome: Identification, Importance, and Management

The prognostic data back up the concern. A systematic review and meta-analysis of coronary CT studies found that the odds of a future acute coronary event were roughly 12 times higher in patients whose plaques had high-risk features compared with those whose plaques did not.10PubMed Central. Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis A secondary analysis of the PROMISE trial showed that patients with high-risk coronary plaque had roughly two and a half times the rate of major adverse cardiovascular events compared with those without such features, a difference that held even after adjusting for how narrow the artery was and standard risk scores.11JAMA Cardiology. Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain

Heterogeneous carotid plaque has also been linked to events beyond just stroke. One study of patients undergoing coronary stenting found that having heterogeneous carotid plaque at baseline predicted future cardiovascular events even after the coronary procedure was done, suggesting that unstable plaque in one part of the body may signal system-wide vulnerability.1PubMed Central. Heterogeneous Carotid Plaque Predicts Cardiovascular Events after Percutaneous Coronary Intervention

How Doctors See Inside the Plaque

Ultrasound is the most accessible tool for characterizing carotid plaque. It is cheap, widely available, and does not involve radiation. Beyond just labeling a plaque as heterogeneous or homogeneous, researchers have refined the approach using a measurement called the gray-scale median, which quantifies how bright or dark the plaque appears on screen. A low gray-scale median suggests a soft, lipid-heavy plaque. In patients with type 2 diabetes, a gray-scale median below 32 was associated with roughly an eightfold increase in the odds of having experienced or developing cardiovascular disease during follow-up.12PubMed Central. Ultrasound analysis of gray-scale median value of carotid plaques is a useful reference index for cerebro-cardiovascular events in patients with type 2 diabetes A separate risk-stratification study showed that combining plaque characteristics like gray-scale median, plaque area, and the presence of discrete white areas (small calcium specks) with standard clinical features substantially improved the ability to predict which patients would go on to have strokes or other cerebrovascular events, pushing the area under the curve to 0.82 versus just 0.59 with stenosis severity alone.13PubMed. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification

MRI provides a different and complementary view. It can detect intraplaque hemorrhage with about 90% sensitivity, though its specificity is more moderate, around 74%.14PubMed. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study That matters because intraplaque hemorrhage is one of the key drivers of plaque growth and destabilization. MRI can also identify the lipid-rich core and distinguish it from fibrous tissue and calcium.15PubMed. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques Serial MRI studies have shown that plaques with hemorrhage at baseline grow faster, with wall volume increasing about 7% over 18 months compared with essentially no change in plaques without hemorrhage, and the lipid core expanding by about 28% versus actually shrinking slightly in controls.16PubMed. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study

In the coronary arteries, CT angiography and intravascular imaging play the roles that ultrasound and MRI play in the neck. Intravascular optical coherence tomography, which threads a tiny probe inside the artery, provides the highest resolution of any current technique and can measure the thickness of the fibrous cap down to the micron level.17PubMed Central. Optical Coherence Tomography and Fibrous Cap Characterization That information is critical because a thin cap over a large lipid pool is the hallmark of the plaque most likely to rupture.

The Calcification Paradox

One of the more counterintuitive findings in plaque biology is that calcium can be either good or bad, depending on its form. Small, scattered specks of calcium, called microcalcifications, are associated with inflammation and instability. They tend to cluster in plaques that are already inflamed and are significantly more common in unstable lesions.18PubMed Central. The Paradox Effect of Calcification in Carotid Atherosclerosis: Microcalcification Is Correlated with Plaque Instability Think of them as a sign that the plaque’s immune battle is still raging.

Large, sheet-like calcification is a different story. It actually appears to stabilize plaques by acting as a physical barrier that walls off the inflammatory core and reduces the chance of rupture. This protective effect is driven in part by vascular smooth muscle cells that shift into a bone-forming mode and lay down solid calcium deposits, dampening the inflammatory cycle.19PubMed. The dark and bright side of atherosclerotic calcification This is why a heavily calcified plaque on an ultrasound is often less worrisome than one with scattered bright spots mixed in among dark soft tissue. Both contain calcium, but the pattern matters enormously.

For patients reading their imaging reports, this means that the word “calcification” is not automatically cause for alarm. What is concerning is the combination of calcification with soft and fibrous components, which is precisely what defines a heterogeneous plaque. The calcium itself is not the villain; the company it keeps determines the risk.

Medication Can Change What a Plaque Looks Like

One of the most encouraging developments in plaque management is the evidence that drugs can push heterogeneous, vulnerable plaques toward a more stable composition. Statins are the best-studied example. Statin therapy is associated with a decrease in soft, low-attenuation plaque material and an increase in dense calcification, effectively accelerating the plaque’s transition from a metabolically active, rupture-prone state to a more inert one.20American College of Cardiology. The Effect of Statin Therapy on the Progression and Composition of Coronary Atherosclerotic Plaque Identified on Coronary CTA A meta-analysis using intravascular ultrasound data confirmed a modest but statistically significant reduction in fibrous plaque volume and an increase in dense calcium volume with statin treatment.21PubMed Central. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies

Newer cholesterol-lowering drugs called PCSK9 inhibitors appear to go further. In patients already on statins, adding a PCSK9 inhibitor progressively shrank the plaque’s lipid core over a year, from about 10% of the plaque at baseline to about 7% at 12 months, while fibrous tissue increased.22PubMed. Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study A separate MRI study reported a 17% reduction in plaque lipid content after just six months of PCSK9 inhibition, a change visible before the plaque’s outer dimensions budged at all, suggesting that lipid content is a more sensitive marker of therapeutic response than plaque size.23PubMed. Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab Coronary studies using near-infrared spectroscopy told a consistent story: the lipid burden within non-culprit plaques shrank significantly more with PCSK9 inhibitor therapy, consistent with stabilization and regression of residual vulnerable plaque.24European Heart Journal – Cardiovascular Imaging. Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study

The practical takeaway is that a heterogeneous plaque finding is not a death sentence. Aggressive lipid-lowering therapy can remodel the plaque toward a safer composition over months to years. How aggressively your doctor pursues this depends on the overall clinical picture, but the biology clearly responds to treatment.

When Surgery Enters the Conversation

For carotid artery disease, surgery (endarterectomy, where the plaque is physically removed) or stenting (where a mesh tube holds the artery open) are the standard interventions when the risk of stroke is considered high enough. Plaque composition influences both the decision to operate and the choice of procedure.

Stenting raises a particular concern in patients with heterogeneous, lipid-rich plaques. During stenting, the balloon and stent physically compress the plaque, which can shatter unstable material and release debris into the bloodstream. A study examining debris caught by embolic protection filters found that heterogeneous, mainly echolucent (soft) plaques carried an extraordinarily elevated risk of releasing macroscopic debris during stenting.25Journal of Vascular Surgery. Impact of plaque dilation before carotid artery stent deployment Age compounds this issue. Older patients tend to have more unstable plaques overall, with larger lipid cores, less smooth muscle cell content, and more calcification, which may partly explain why randomized trials consistently show higher procedural stroke rates in elderly patients undergoing carotid stenting.26PubMed. Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting

Surgical endarterectomy, which removes the plaque entirely rather than squishing it, may be safer in these cases, and many vascular surgeons already lean toward endarterectomy when imaging shows a soft, mixed-composition plaque. The presence of heterogeneous plaque on an ultrasound is one of the factors that can tip the scales toward an operation, even in patients whose degree of narrowing alone might not clearly warrant it.

Sex Differences in Plaque Vulnerability

Plaque biology is not identical in men and women. A large meta-analysis found that men are significantly more likely to have plaques containing a lipid-rich necrotic core, intraplaque hemorrhage, and ulceration compared with women.27PubMed Central. Sex Differences in Carotid Atherosclerosis: A Systematic Review and Meta-Analysis Men’s plaques also tend to develop these dangerous features at a younger age, with larger lipid cores, thinner fibrous caps, and stronger inflammatory responses driving greater vulnerability earlier in life.28PubMed Central. Sex differences in features of atherosclerotic plaques as revealed by various imaging techniques: historical review

That gap narrows after menopause. The loss of estrogen’s protective effects on smooth muscle cell density and calcification patterns causes a rapid escalation of plaque instability in older women. By the time men and women reach their 70s and beyond, their overall atherosclerotic burden is comparable. The mechanisms driving instability differ at a cellular level, though. Single-cell analyses of carotid plaques have revealed that in men, unstable plaques are characterized by a loss of contractile smooth muscle cells and a surge in inflammatory macrophages and activated immune cells. In women, unstable plaques retain more contractile smooth muscle cells but show an expansion of certain cytotoxic immune cells and foam-cell macrophages.29PubMed. Single-Cell Spatial Transcriptomics Reveals Sex-Specific Differences Driving Carotid Atherosclerotic Plaque Instability These differences could eventually matter for treatment, though sex-specific plaque therapies remain a research frontier rather than a clinical reality.

AI-Assisted Plaque Reading

One of the challenges with plaque characterization on ultrasound is that it depends on the operator’s skill and judgment. Two sonographers reading the same image can disagree on whether a plaque is heterogeneous or homogeneous, and that subjectivity limits the reliability of the assessment. Artificial intelligence is starting to change this. A recent meta-analysis of deep learning and radiomics approaches for carotid plaque detection found that both methods showed strong diagnostic performance, with summary area-under-the-curve values of 0.95 and 0.92, respectively.30PubMed Central. Diagnostic Performance of Deep Learning and Radiomics in Extracranial Carotid Plaque Detection: Systematic Review and Meta-Analysis A separate meta-analysis focused specifically on machine learning models for identifying culprit (dangerous) carotid plaques on ultrasound reported a sensitivity of 0.84 and specificity of 0.82.31PubMed Central. Radiomics-based machine learning atherosclerotic carotid artery disease in ultrasound: systematic review with meta-analysis of RQS

These tools are not in widespread clinical use yet, but the direction is clear. Automated plaque analysis could reduce inter-operator variability, catch subtle texture patterns that human eyes miss, and potentially flag high-risk heterogeneous plaques earlier. For patients, this means that the imaging report you receive in a few years may be more detailed and more reliable than what is possible today. Meanwhile, researchers are also investigating circulating blood biomarkers, including markers of inflammation, lipid metabolism, and blood-vessel leakiness, that might one day complement imaging by signaling plaque instability without a scan at all.32PubMed Central. Circulating biomarkers of carotid plaque vulnerability: current evidence, emerging markers, and barriers to clinical implementation